- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Functional dyspepsia, also known as non-ulcer dyspepsia or indigestion, is a term used to describe a group of symptoms affecting the gastrointestinal tract, including stomach pain or discomfort, nausea, bloating and belching. The condition is diagnosed when no obvious cause can be found for the symptoms present, though a small percentage of cases are caused by infection with the germ Helicobacter pylori.
According to our latest study, the global Functional Dyspepsia Drug market size was valued at USD 6121.1 million in 2022 and is forecast to a readjusted size of USD 7365.8 million by 2029 with a CAGR of 2.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumer of Functional Dyspepsia Drug in global market, with a consumption market share of 38.71% in 2019. Market is not concentrated.
This report is a detailed and comprehensive analysis for global Functional Dyspepsia Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Functional Dyspepsia Drug market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Functional Dyspepsia Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Functional Dyspepsia Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (US$/Unit), 2018-2029
Global Functional Dyspepsia Drug market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Functional Dyspepsia Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Functional Dyspepsia Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Sumitomo, Cadila Pharmaceuticals, Teva and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Functional Dyspepsia Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
Market segment by Application
Hospitals
Drugstores
Major players covered
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Functional Dyspepsia Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Functional Dyspepsia Drug, with price, sales, revenue and global market share of Functional Dyspepsia Drug from 2018 to 2023.
Chapter 3, the Functional Dyspepsia Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Functional Dyspepsia Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Functional Dyspepsia Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Functional Dyspepsia Drug.
Chapter 14 and 15, to describe Functional Dyspepsia Drug sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Functional Dyspepsia Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Functional Dyspepsia Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Prokinetic Drugs
1.3.3 Gastric Antisecretory Drugs
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Functional Dyspepsia Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Drugstores
1.5 Global Functional Dyspepsia Drug Market Size & Forecast
1.5.1 Global Functional Dyspepsia Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Functional Dyspepsia Drug Sales Quantity (2018-2029)
1.5.3 Global Functional Dyspepsia Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Functional Dyspepsia Drug Product and Services
2.1.4 Bayer Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bayer Recent Developments/Updates
2.2 Sumitomo
2.2.1 Sumitomo Details
2.2.2 Sumitomo Major Business
2.2.3 Sumitomo Functional Dyspepsia Drug Product and Services
2.2.4 Sumitomo Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sumitomo Recent Developments/Updates
2.3 Cadila Pharmaceuticals
2.3.1 Cadila Pharmaceuticals Details
2.3.2 Cadila Pharmaceuticals Major Business
2.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Product and Services
2.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Cadila Pharmaceuticals Recent Developments/Updates
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva Functional Dyspepsia Drug Product and Services
2.4.4 Teva Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Teva Recent Developments/Updates
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Functional Dyspepsia Drug Product and Services
2.5.4 Johnson & Johnson Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments/Updates
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Functional Dyspepsia Drug Product and Services
2.6.4 Pfizer Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Functional Dyspepsia Drug Product and Services
2.7.4 Sanofi Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi Recent Developments/Updates
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Functional Dyspepsia Drug Product and Services
2.8.4 AstraZeneca Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 AstraZeneca Recent Developments/Updates
2.9 Jiangsu Aosaikang Pharma
2.9.1 Jiangsu Aosaikang Pharma Details
2.9.2 Jiangsu Aosaikang Pharma Major Business
2.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product and Services
2.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Jiangsu Aosaikang Pharma Recent Developments/Updates
2.10 Eisai
2.10.1 Eisai Details
2.10.2 Eisai Major Business
2.10.3 Eisai Functional Dyspepsia Drug Product and Services
2.10.4 Eisai Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eisai Recent Developments/Updates
2.11 Kyowa Kirin Pharmaceuticals
2.11.1 Kyowa Kirin Pharmaceuticals Details
2.11.2 Kyowa Kirin Pharmaceuticals Major Business
2.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product and Services
2.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Kyowa Kirin Pharmaceuticals Recent Developments/Updates
2.12 Hanmi Pharm
2.12.1 Hanmi Pharm Details
2.12.2 Hanmi Pharm Major Business
2.12.3 Hanmi Pharm Functional Dyspepsia Drug Product and Services
2.12.4 Hanmi Pharm Functional Dyspepsia Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hanmi Pharm Recent Developments/Updates
3 Competitive Environment: Functional Dyspepsia Drug by Manufacturer
3.1 Global Functional Dyspepsia Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Functional Dyspepsia Drug Revenue by Manufacturer (2018-2023)
3.3 Global Functional Dyspepsia Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Functional Dyspepsia Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Functional Dyspepsia Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Functional Dyspepsia Drug Manufacturer Market Share in 2022
3.5 Functional Dyspepsia Drug Market: Overall Company Footprint Analysis
3.5.1 Functional Dyspepsia Drug Market: Region Footprint
3.5.2 Functional Dyspepsia Drug Market: Company Product Type Footprint
3.5.3 Functional Dyspepsia Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Functional Dyspepsia Drug Market Size by Region
4.1.1 Global Functional Dyspepsia Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Functional Dyspepsia Drug Consumption Value by Region (2018-2029)
4.1.3 Global Functional Dyspepsia Drug Average Price by Region (2018-2029)
4.2 North America Functional Dyspepsia Drug Consumption Value (2018-2029)
4.3 Europe Functional Dyspepsia Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Functional Dyspepsia Drug Consumption Value (2018-2029)
4.5 South America Functional Dyspepsia Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Functional Dyspepsia Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Functional Dyspepsia Drug Sales Quantity by Type (2018-2029)
5.2 Global Functional Dyspepsia Drug Consumption Value by Type (2018-2029)
5.3 Global Functional Dyspepsia Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Functional Dyspepsia Drug Sales Quantity by Application (2018-2029)
6.2 Global Functional Dyspepsia Drug Consumption Value by Application (2018-2029)
6.3 Global Functional Dyspepsia Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Functional Dyspepsia Drug Sales Quantity by Type (2018-2029)
7.2 North America Functional Dyspepsia Drug Sales Quantity by Application (2018-2029)
7.3 North America Functional Dyspepsia Drug Market Size by Country
7.3.1 North America Functional Dyspepsia Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Functional Dyspepsia Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Functional Dyspepsia Drug Sales Quantity by Type (2018-2029)
8.2 Europe Functional Dyspepsia Drug Sales Quantity by Application (2018-2029)
8.3 Europe Functional Dyspepsia Drug Market Size by Country
8.3.1 Europe Functional Dyspepsia Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Functional Dyspepsia Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Functional Dyspepsia Drug Market Size by Region
9.3.1 Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Functional Dyspepsia Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Functional Dyspepsia Drug Sales Quantity by Type (2018-2029)
10.2 South America Functional Dyspepsia Drug Sales Quantity by Application (2018-2029)
10.3 South America Functional Dyspepsia Drug Market Size by Country
10.3.1 South America Functional Dyspepsia Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Functional Dyspepsia Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Functional Dyspepsia Drug Market Size by Country
11.3.1 Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Functional Dyspepsia Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Functional Dyspepsia Drug Market Drivers
12.2 Functional Dyspepsia Drug Market Restraints
12.3 Functional Dyspepsia Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Functional Dyspepsia Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Functional Dyspepsia Drug
13.3 Functional Dyspepsia Drug Production Process
13.4 Functional Dyspepsia Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Functional Dyspepsia Drug Typical Distributors
14.3 Functional Dyspepsia Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Functional Dyspepsia Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Functional Dyspepsia Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Functional Dyspepsia Drug Product and Services
Table 6. Bayer Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Bayer Recent Developments/Updates
Table 8. Sumitomo Basic Information, Manufacturing Base and Competitors
Table 9. Sumitomo Major Business
Table 10. Sumitomo Functional Dyspepsia Drug Product and Services
Table 11. Sumitomo Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sumitomo Recent Developments/Updates
Table 13. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Cadila Pharmaceuticals Major Business
Table 15. Cadila Pharmaceuticals Functional Dyspepsia Drug Product and Services
Table 16. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Cadila Pharmaceuticals Recent Developments/Updates
Table 18. Teva Basic Information, Manufacturing Base and Competitors
Table 19. Teva Major Business
Table 20. Teva Functional Dyspepsia Drug Product and Services
Table 21. Teva Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Teva Recent Developments/Updates
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Functional Dyspepsia Drug Product and Services
Table 26. Johnson & Johnson Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Johnson & Johnson Recent Developments/Updates
Table 28. Pfizer Basic Information, Manufacturing Base and Competitors
Table 29. Pfizer Major Business
Table 30. Pfizer Functional Dyspepsia Drug Product and Services
Table 31. Pfizer Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Pfizer Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Functional Dyspepsia Drug Product and Services
Table 36. Sanofi Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi Recent Developments/Updates
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Major Business
Table 40. AstraZeneca Functional Dyspepsia Drug Product and Services
Table 41. AstraZeneca Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. AstraZeneca Recent Developments/Updates
Table 43. Jiangsu Aosaikang Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Jiangsu Aosaikang Pharma Major Business
Table 45. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product and Services
Table 46. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Jiangsu Aosaikang Pharma Recent Developments/Updates
Table 48. Eisai Basic Information, Manufacturing Base and Competitors
Table 49. Eisai Major Business
Table 50. Eisai Functional Dyspepsia Drug Product and Services
Table 51. Eisai Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Eisai Recent Developments/Updates
Table 53. Kyowa Kirin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Kyowa Kirin Pharmaceuticals Major Business
Table 55. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product and Services
Table 56. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Kyowa Kirin Pharmaceuticals Recent Developments/Updates
Table 58. Hanmi Pharm Basic Information, Manufacturing Base and Competitors
Table 59. Hanmi Pharm Major Business
Table 60. Hanmi Pharm Functional Dyspepsia Drug Product and Services
Table 61. Hanmi Pharm Functional Dyspepsia Drug Sales Quantity (M Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hanmi Pharm Recent Developments/Updates
Table 63. Global Functional Dyspepsia Drug Sales Quantity by Manufacturer (2018-2023) & (M Units)
Table 64. Global Functional Dyspepsia Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Functional Dyspepsia Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Functional Dyspepsia Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Functional Dyspepsia Drug Production Site of Key Manufacturer
Table 68. Functional Dyspepsia Drug Market: Company Product Type Footprint
Table 69. Functional Dyspepsia Drug Market: Company Product Application Footprint
Table 70. Functional Dyspepsia Drug New Market Entrants and Barriers to Market Entry
Table 71. Functional Dyspepsia Drug Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Functional Dyspepsia Drug Sales Quantity by Region (2018-2023) & (M Units)
Table 73. Global Functional Dyspepsia Drug Sales Quantity by Region (2024-2029) & (M Units)
Table 74. Global Functional Dyspepsia Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Functional Dyspepsia Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Functional Dyspepsia Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Functional Dyspepsia Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Functional Dyspepsia Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 79. Global Functional Dyspepsia Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 80. Global Functional Dyspepsia Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Functional Dyspepsia Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Functional Dyspepsia Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Functional Dyspepsia Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Functional Dyspepsia Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 85. Global Functional Dyspepsia Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 86. Global Functional Dyspepsia Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Functional Dyspepsia Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Functional Dyspepsia Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Functional Dyspepsia Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Functional Dyspepsia Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 91. North America Functional Dyspepsia Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 92. North America Functional Dyspepsia Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 93. North America Functional Dyspepsia Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 94. North America Functional Dyspepsia Drug Sales Quantity by Country (2018-2023) & (M Units)
Table 95. North America Functional Dyspepsia Drug Sales Quantity by Country (2024-2029) & (M Units)
Table 96. North America Functional Dyspepsia Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Functional Dyspepsia Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Functional Dyspepsia Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 99. Europe Functional Dyspepsia Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 100. Europe Functional Dyspepsia Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 101. Europe Functional Dyspepsia Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 102. Europe Functional Dyspepsia Drug Sales Quantity by Country (2018-2023) & (M Units)
Table 103. Europe Functional Dyspepsia Drug Sales Quantity by Country (2024-2029) & (M Units)
Table 104. Europe Functional Dyspepsia Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Functional Dyspepsia Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 107. Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 108. Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 109. Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 110. Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Region (2018-2023) & (M Units)
Table 111. Asia-Pacific Functional Dyspepsia Drug Sales Quantity by Region (2024-2029) & (M Units)
Table 112. Asia-Pacific Functional Dyspepsia Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Functional Dyspepsia Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Functional Dyspepsia Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 115. South America Functional Dyspepsia Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 116. South America Functional Dyspepsia Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 117. South America Functional Dyspepsia Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 118. South America Functional Dyspepsia Drug Sales Quantity by Country (2018-2023) & (M Units)
Table 119. South America Functional Dyspepsia Drug Sales Quantity by Country (2024-2029) & (M Units)
Table 120. South America Functional Dyspepsia Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Functional Dyspepsia Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Type (2018-2023) & (M Units)
Table 123. Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Type (2024-2029) & (M Units)
Table 124. Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Application (2018-2023) & (M Units)
Table 125. Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Application (2024-2029) & (M Units)
Table 126. Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Region (2018-2023) & (M Units)
Table 127. Middle East & Africa Functional Dyspepsia Drug Sales Quantity by Region (2024-2029) & (M Units)
Table 128. Middle East & Africa Functional Dyspepsia Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Functional Dyspepsia Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Functional Dyspepsia Drug Raw Material
Table 131. Key Manufacturers of Functional Dyspepsia Drug Raw Materials
Table 132. Functional Dyspepsia Drug Typical Distributors
Table 133. Functional Dyspepsia Drug Typical Customers
List of Figures
Figure 1. Functional Dyspepsia Drug Picture
Figure 2. Global Functional Dyspepsia Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Functional Dyspepsia Drug Consumption Value Market Share by Type in 2022
Figure 4. Prokinetic Drugs Examples
Figure 5. Gastric Antisecretory Drugs Examples
Figure 6. Others Examples
Figure 7. Global Functional Dyspepsia Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Functional Dyspepsia Drug Consumption Value Market Share by Application in 2022
Figure 9. Hospitals Examples
Figure 10. Drugstores Examples
Figure 11. Global Functional Dyspepsia Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Functional Dyspepsia Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Functional Dyspepsia Drug Sales Quantity (2018-2029) & (M Units)
Figure 14. Global Functional Dyspepsia Drug Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Functional Dyspepsia Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Functional Dyspepsia Drug Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Functional Dyspepsia Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Functional Dyspepsia Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Functional Dyspepsia Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Functional Dyspepsia Drug Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Functional Dyspepsia Drug Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Functional Dyspepsia Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Functional Dyspepsia Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Functional Dyspepsia Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Functional Dyspepsia Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Functional Dyspepsia Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Functional Dyspepsia Drug Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Functional Dyspepsia Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Functional Dyspepsia Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Functional Dyspepsia Drug Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Functional Dyspepsia Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Functional Dyspepsia Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Functional Dyspepsia Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Functional Dyspepsia Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Functional Dyspepsia Drug Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Functional Dyspepsia Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Functional Dyspepsia Drug Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Functional Dyspepsia Drug Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Functional Dyspepsia Drug Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Functional Dyspepsia Drug Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Functional Dyspepsia Drug Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Functional Dyspepsia Drug Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Functional Dyspepsia Drug Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Functional Dyspepsia Drug Consumption Value Market Share by Region (2018-2029)
Figure 53. China Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Functional Dyspepsia Drug Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Functional Dyspepsia Drug Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Functional Dyspepsia Drug Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Functional Dyspepsia Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Functional Dyspepsia Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Functional Dyspepsia Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Functional Dyspepsia Drug Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Functional Dyspepsia Drug Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Functional Dyspepsia Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Functional Dyspepsia Drug Market Drivers
Figure 74. Functional Dyspepsia Drug Market Restraints
Figure 75. Functional Dyspepsia Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Functional Dyspepsia Drug in 2022
Figure 78. Manufacturing Process Analysis of Functional Dyspepsia Drug
Figure 79. Functional Dyspepsia Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
